FIGURE 1.

Propofol exposure reduced cell malignant behaviors in non‐small cell lung cancer (NSCLC) cells. (a and b) 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assays were used to investigate the effects of different concentrations of propofol on NSCLC cell viability. (c and d) Colony formation and flow cytometry assays were used to determine cell proliferation and apoptosis in NSCLC cells with propofol (10 μg/mL) exposure. (e and f) Western blotting was used to analyze cleaved caspase‐3 and proliferating cell nuclear antigen (PCNA) protein levels in NSCLC cells with propofol (10 μg/mL) exposure. (g and h) Transwell assays were used to detect cell migration and invasion in NSCLC cells with propofol (10 μg/mL) exposure. *p < 0.05.